Top Back to top

Evaluation of the EBMT risk score and of a modified EBMT risk score adapted to paediatric patients in paediatric allogeneic transplantation

Paediatric Diseases Working Party (PDWP)
Other society
Study type:
Study number:
 
Type of Stem Cell Treatment:
Allogeneic
Diseases:
 
Short title:
 
Primary objective:
To assess EBMT risk score in paediatric allogeneic transplantation. To test a modified EBMT risk score with age classes adapted to paediatrics.
Key inclusion criteria:
all patients
-Aged <18 Yrs at HSCT
-Allogeneic HSCT in an EBMT registered center for an acquired haematological disease
-Date of transplant between 01.01.2000 and 31.12.2012
Country:
 
Principal investigator:
Fanette Bernard
EBMT Study coordinator:
Arnaud Dalissier